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A simple high-performance liquid chromatography (HPLC) method coupled with an
evaporative light scattering detector (ELSD) was developed for the determination of azi-
thromycin in raw materials and pharmaceutical formulations (injections, capsules and
tablets) without any pretreatment or derivatization step. Azithromycin, degradation
products and formulation ingredients were separated efficiently by using the mobile phase
consisted of ammonium acetate (0.05 M, pH 8.0) and acetonitrile (60:40, v/v) in an isocratic
mode at 0.8 ml/min flow rate. Parameters of ELSD were 60 C for evaporation temperature
and 50 psi for pressure of carrier gas (air). A logarithmic calibration curve was obtained
from 50.93 to 509.30 mg/ml (r ¼ 0.9996) for azithromycin, with the limit of detection (LOD) of
6.75 mg/ml (S/n ¼ 3) and the limit of quantification of 22.50 mg/ml (S/n ¼ 10). The developed
method was validated and applied with satisfactory accuracy and precision for the
determination of azithromycin in raw materials and pharmaceutical formulations (re-
covery 99e102%, RSD <1.2%, n ¼ 3). No significant difference (t-test) was found between the
results of the developed HPLCeELSD method and the HPLCeUV or microbiological method.
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erythromycin (B).Azithromycin (AZM) is a novel macrolide antibiotic and a
semisynthetic- erythromycin derivative. It has a methyl-
substituted nitrogen at position 9a in the lactone ring to
create a 15-membered-ring macrolide [1]. AZM produces an
enhanced spectrum and potency against bacteria compared
with other macrolides and superior stability in acid envi-
ronment. Its mechanism is similar to erythromycin,
appearing to bind to the same receptor, 50s ribosomal
subunits of susceptible bacteria and suppresses protein
synthesis. AZM has greater oral bioavailability, longer
elimination half-lives and much higher tissue concentra-
tions than erythromycin in animals and humans, which
plays a leading role in the treatment or prophylaxis of
several diseases such as bacterial upper and lower respi-
ratory tract infections, urinary tract infections, skin and
soft tissue infections, and sexually transmitted diseases
[2,3].
A number of reports have been published regarding to
the determination of AZM, in which microbiological
method was the general content assay method [4] with
disadvantages of time-consuming, low detectability and
poor precision. In order to overcome these problems,
several high-performance liquid chromatography (HPLC)
methods have been developed. The official method [5e8] for
the assay of AZM in pharmaceuticals is HPLC with UV de-
tector, but AZM has only a weak UV absorbance in the
wavelength range of less than 220 nm, leading to an
asymmetric peak profile and low column efficiency. Other
methods, including electrochemical detection [9e12], fluo-
rescence detection by pre-column derivatization [13e15]
and liquid chromatographyemass spectrometry (LCeMS)
[16e18] have been used to determine AZM in routine
pharmaceutical dosage forms or biological matrices. Obvi-
ously, electrochemical detectors are not widely available in
many laboratories. The USP method [19] describes a high
pH mobile phase (pH11) as well as a specific column
“Gamma-alumina” which is quite expensive and difficult to
obtain in order to assay AZM using an amperometric elec-
trochemical detector. Moreover, pre-column derivatization
is time-consuming due to the complex steps involved. Also,
it would be unrealistic to use LCeMS for the routine quality
control of AZM preparations. Therefore, it is necessary to
develop a convenient and effective method for the quality
control of AZM by using conventional materials, reagents
and equipment.
Evaporative light scattering detector (ELSD) is described as
a quasi-universal detection mode suitable for non-absorbing
analytes [20e22] and end-absorbing analytes [23e25]. The
response does not depend on the solute optical properties, but
on the size, shape and surface properties of the particle
formed, any compound having lower volatility than the mo-
bile phase can be detected. ELSD operation principle mainly
consists of three successive processes: (a) nebulization of
chromatographic eluent using nitrogen or air, (b) evaporation
of mobile phase at relatively low temperature and (c) light
scattering by the non-volatile residual particles, which ideally
consist of analytemolecules [26,27]. This complexmechanismleads to a non-linear empirical quantitative law described by
the relation:
A ¼ amb
where A is the area of the chromatographic peak, m the
mass of the analyte, a the response factor and b is the
response index measured from the slope of the curve log
A ¼ f(logm) [i.e. logA ¼ blogm þ loga]. The coefficients a and b
depend on many parameters, such as the average size, the
shape and the distribution of the particles, the nature, the
volatility and the concentration of the analyte, the nature of
the mobile phase and nebulizing gas, the liquid and gas
flowrates, evaporation temperature, etc. In the field of
pharmaceutical analysis, it has already been proposed as an
effective alternative for both the determination of the ami-
noglycoside antibiotics, natural medicines [28], compound
medicines and assessing the separation of drug combination
[29].
The purpose of this study was to develop and validate a
rapid and simple HPLC method with ELSD detection for the
determination of AZM. The composition and flow rate of
mobile phase and the column temperature of the method
were optimized by using an orthogonal experimental design
at four levels. The results proved the established method is
precise, accurate, robust and practical, and is suitable for the
routine quality control of AZM in raw materials and phar-
maceutical dosage forms.
Table 1 e L16 (4
5) 5 factors-4 levels orthogonal test.
Factor
level
A (concentration of
ammonium acetate)/(mol/l)
B (content
of acetonitrile)/%
C (value of pH) D (column
temperature)/C
E (flow rate)/
ml/min
1 0.08 48 7.5 25 0.6
2 0.05 45 7.8 30 0.8
3 0.03 43 8.0 35 1.0
4 0.01 40 8.3 40 1.2
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2.1. Materials
HPLC grade acetonitrile was obtained from Tianjin Concord
International Trade Co., Ltd. (China). Analytical grade
ammonium acetate was supplied by Tianjin Kermel Chemical
Reagent Co., Ltd. (China). Other chemicals were of analytical
grade.Waterwas purified by redistillation and passed through
a 0.45 mmmembrane filter before use. AZM standard (931 units
per mg), AZM reference substance (92.2% of purity) and
erythromycin standard (931 units per mg) were purchased
from the National Institute for Control of Pharmaceutical and
Biological Products (Beijing, China). The structures of these
compounds are shown in Fig. 1. The raw materials and for-
mulations (injections, capsules, tablets) of AZMwere provided
by local pharmaceutical companies (Xi’an, China),Table 2 e The program and results of orthogonal test and vari
Test no. A B C D E
1 1 1 1 1 1
2 1 2 2 2 2
3 1 3 3 3 3
4 1 4 4 4 4
5 2 1 2 3 4
6 2 2 1 4 3
7 2 3 4 1 2
8 2 4 3 2 1
9 3 1 3 4 2
10 3 2 4 3 1
11 3 3 1 2 4
12 3 4 2 1 3
13 4 1 4 2 3
14 4 2 3 1 4
15 4 3 2 4 1
16 4 4 1 3 2
K1 15.69 17.73 17.59 19.37 19.88
K2 22.70 18.96 21.46 15.09 21.04
K3 21.16 21.28 22.37 22.04 20.02
K4 21.39 22.98 19.53 24.44 20.02
R 7.005 5.248 4.778 9.352 1.159
Factor Error sum of squares De
A 115.593
B 66.026
C 54.200
D 192.757
E 3.474
Error 3.47
P < 0.05: significant difference.accompanied with certificate of analysis based on Chinese
Pharmacopoeia.2.2. Apparatus and chromatographic conditions
Liquid chromatography was performed with Agilent 1200
system (Agilent Technologies, USA) equipment comprising a
quaternary pump, a G1329 A autosampler and a G1316 A col-
umn oven. Chromatographic separation was performed on
250 mm  4.6 mm, i.d., 5 mm particle size, pore diameter 100
A, Boston pHlex ODS reversed phase column at 40 Cwith the
mobile phase consisted of ammonium acetate (0.05 M, pH 8.0)
and acetonitrile in the proportion of 60:40 (v/v). Before being
mixed with the acetonitrile, the ammonium acetate (0.05 M)
was adjusted to pH 8.0 by triethylamine and filtered through
0.45 mm nylon membrane. The flow rate of the mobile phase
was 0.8 ml/min and the volume of each injection was 10 ml.ance analysis.
Tailing
factor (T)
Peak
width (W)
Theoretical
plates (N)
Colligation
score
1.31 1.2767 360 9.31
1.94 0.4900 3226 11.3
1.25 0.3267 4458 20.45
0.71 0.2500 7391 21.71
0.84 0.1517 6226 23
0.81 0.1583 6412 22.76
1.14 0.2300 5371 22.97
1.39 0.2883 8383 22.06
1.05 0.2100 7834 25.79
1.44 0.3083 7210 20.63
1.70 0.2767 1502 14.19
0.68 0.2500 11093 24.04
1.73 0.3500 804 12.81
0.81 0.1450 4013 21.16
0.86 0.2167 13031 27.51
0.79 0.1767 8769 24.09
/ / / /
/ / / /
/ / / /
/ / / /
/ / / /
gree of freedom F P
3 33.274 <0.05
3 19.006 <0.05
3 15.602 <0.05
3 55.486 <0.05
3 1.000
3 / /
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tering detector (SofTA Corporation, USA). The drift tube tem-
perature of the ELSD was 60 C. The nebulizer gas was air of
industrial purity grade provided by a CA-2 quiet oil-free air
pump and the pressure of nebulizing gas was 50 psi. In these
conditions AZM retention time was roughly 16 min. All data
acquired were processed by Agilent Chemstation Rev. B. 04.01
software (Agilent, Palo Alto, CA).2.3. Solution preparation
2.3.1. Stock and working standard solutions
Stock solutionsofAZMwereprepared, 55.24mgAZMreference
substance (equivalent to 50.93 mg AZM) was transferred to a
100ml volumetric flask, followedby the additionof about 50ml
mobile phase and sonicated for 15min, thenmadeup to 100ml
withmobile phase.Working standard solutionswere prepared
by further dilution of the AZM stock solution with the mobile
phase to furnish five different concentrationswithin the range
of interest, in this work 50.93, 101.86, 152.79, 254.66 and
509.30 mg/ml, then filtered through a 0.45 mmmembrane filter.Fig. 2 e Representative chromatograms of erythromycin and AZ
natural light and UV lamp (B), and treated with heat (C), 1 M alk
erythromycin; 3,4,5,6,7,8, degradation products (unknown impu2.3.2. Reference standard solution
Reference standard solution of AZM was prepared at con-
centration of 0.25 mg/ml, and used for the evaluation of the
precision and stability of the method.
2.4. Sample preparation
Drug substances were accurately weighed and dissolved in
mobile phase to obtain a concentration level within the
working range. Concentrations of AZM solution were 0.25 mg/
ml for the assay of AZM.
2.5. Procedure
Before measurements, the column was equilibrated for at
least 1 h with mobile phase flowing through the chro-
matographic system until baseline noise became negligible
(less than 0.5 mV at detector gain 8). 10 ml of the standard
or sample solutions were injected into the chromatograph
using conditions described above (each solution was injec-
ted in twice).M as standard (A) and AZM raw materials exposed to
ali (D), 1 M acid (E) and 1% hydrogen peroxide (F). 1, AZM; 2,
rities).
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3.1. Optimization of separation conditions
AZM contains two nitrogen atoms, which make it a weakly
basic compound. There have always been problems in
analyzing drugs like AZM because of their basic properties.
These compounds will interact strongly with the polar ends of
the HPLC column packing materials (for example, residual
silanol groups), becoming adsorbed to the column and are not
easily eluted by the mobile phase. Therefore, asymmetric
peaks are often observed under these conditions. Moreover,
ELSD demands the evaporation of the mobile phase prior to
light scattering step, mobile phases of high volatility are
required. Several chromatography systems were investigated
by us to resolve these difficulties: acetonitrile was selected for
the organic phase instead of methanol because of its higher
eluting ability. The aqueous phase, involving ammonium
formate or ammonium acetate solutions, was mixed with
acetonitrile. Different pH values of the aqueous phase were
investigated because increasing or decreasing the ionization
of AZM by pH adjustment can change the column retention of
AZM. Triethylamine, an organic modifier, was used for
improving the peak shape of AZM with amino groups and
increasing the baseline noise.Fig. 3 e Representative chromatograms of AZM capsules blank e
UV lamp (B), and treated with heat (C), 1 M alkali (D), 1 M acid (
degradation products (unknown impurities).After a preliminary crude optimization, orthogonal exper-
iment [30,31] was applied for the final optimization of mobile
phase ratio, concentration and pH values of the aqueous
phase, flow rate of the mobile phase and the column tem-
perature (totally five parameters). Three response variables
were considered for the evaluation of the efficiency of the
chromatographic determination: (i) asymmetry factor, (ii)
peak width, (iii) numbers of theoretical plate. The orthogonal
design table L16 (4
5) was used and test program is shown in
Table 1 and 2.
The program and results of orthogonal test and variance
analysiswere shown in Table 2, and the optimum resultswere
obtained as follow: themobile phase consisting of ammonium
acetate (0.05 M, pH 8.0) and acetonitrile in the proportion of
60:40 (v/v), an isocratic mode at a rate of 0.8 ml/min. The
chromatogram system showed sharp symmetrical peaks and
good separation, AZM and its impurities could be eluted with
baseline separation in 25 min.
3.2. Optimization of ELSD conditions
The critical parameters of ELSD are the temperature of the
tube (Ttub) and the gas pressure (Pressure). These were not
included in the orthogonal experimental optimization, since
they appear a minor influence on the chromatographic sepa-
ration comparing to mobile phase composition. However,xcipient (A) and AZM capsules exposed to natural light and
E) and 1% hydrogen peroxide (F). 1, AZM; 2,3,4,5,6,7,
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 1 0 7e1 1 6112depending on the nature of the analyte, they may appear a
greater impact on the detectability and sensitivity of the
method. Using the optimized mobile phase, a two-step uni-
variate optimization was conducted. In the first step, the drift
tube temperature recommended was 60 C. Based on this,
various temperatures range from 45 to 80 C were tested to
study the influence on ELSD response and signal-to-noise
ratio. The results showed that the optimal parameter was
identified as 60 C. In the second step, using the optimumdrift
tube temperature, the pressure of nebulizing gas recom-
mended was 50 psi. Based on this, various pressures (45, 50
and 55 psi) were tested to study the influence on ELSD
response and signal-to-noise ratio, and the results showed
that it is no considerable influence on the detector response
(peak area) was observed. Therefore, best results were ob-
tained for 60 C and 50 psi, respectively.3.3. System suitability
Fig. 2A illustrates a typical chromatogram of AZM and eryth-
romycin, which might be the major impurity in the synthesis
of AZM [7], using the optimum chromatographic conditions.
The retention time of erythromycin and AZM were 13 and
15.5 min, respectively. Two chromatographic peaks wereFig. 4 e Representative chromatograms of AZM injections blank
and UV lamp (B), and treated with heat (C), 1 M alkali (D), 1 M a
degradation products (unknown impurities).obtained with good resolution (R ¼ 3.15) showing that AZM
peak was free of interference of erythromycin.3.4. Validation of the method
The procedures and method characteristics used for valida-
tion of this method were those described in the International
Conference of Harmonization (ICH) Guidelines [32]. Speci-
ficity, linearity, precision, stability and durability of the
method were evaluated. Limits of detection and quantifica-
tion, accuracy and repeatability were also calculated.
3.4.1. Specificity
The ability of the chromatographic system to resolve AZM
from its degradation products and formulation excipients was
investigated. The raw materials, different formulations of
AZM and all excipients were stored under relevant stress
conditions (light, heat, acid/base hydrolysis and oxidation,
respectively). Figs. 2e5 show the chromatograms obtained
from these samples. The samples showed light stability while
degradation products were produced under heat, acid/base
hydrolysis and oxidation conditions. Specificity was demon-
strated showing that neither formulation excipients nor
degradation products interfered with quantification ofexcipient (A) and AZM injections exposed to natural light
cid (E) and 30% hydrogen peroxide (F). 1, AZM; 2,3,4,5,6,
Fig. 5 e Representative chromatograms of AZM tablets blank excipient (A) and AZM tablets exposed to natural light and UV
lamp (B), and treated with heat (C), 1 M alkali (D), 1 M acid (E) and 1% hydrogen peroxide (F). 1, AZM; 2,3,4,5,6,7, degradation
products (unknown impurities).
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used in a stability assay.
3.4.2. Linearity of response
Linearity is determinedexperimentallybyanalysis of a seriesof
standards at five different concentrations that span at least
80e120%of theexpectedworking rangeof theassay. Ithas been
generally observed that the detector response, as measured by
peak area, varies exponentially with the mass of analyte, and
this behavior can be mathematically expressed in logarithmic
form. Present experimental results showed that the logarithm
of peak area of each standard was linearly correlated to the
logarithm of injected concentration within a particular range.
In this investigation, a linear plot was obtained from five
AZMstandard solutions of different concentration in the range
50.93e509.30 mg/ml (20e200% of theoretical value) using two
replicate injections. The corresponding coefficient (r ¼ 0.9996)
was achieved with the well-established exponential relation-
ship between peak area and sample concentration:
logA¼ 1.3142 logCþ 0.2359. The result indicated good linearity.
3.4.3. Precision of the assay
The precision of the method was determined by injecting the
working standard six times in succession, and the relative
standard deviation (RSD) of the six peak areas was calculated.Reference standard solution and samples solution of AZM at
100% of the test concentration (0.25mg/ml) were prepared and
then assayed for AZM using the recommended HPLC system.
RSD values were better than 1.5%.
3.4.4. Limit of detection (LOD) and quantification (LOQ)
The limit of detection (LOD) is defined as the lowest absolute
concentration of the analyte that can be accurately detected
but not necessarily quantified under the stated experimental
condition and the limit of quantification (LOQ), taken as the
lowest absolute concentration of the analyte in the sample
which can be determined with acceptable precision and ac-
curacy under the stated experimental condition. Their deter-
mination both could be made by the calculation of the signal-
to-noise ratio. A ratio of 3 was selected and successive di-
lutions of the reference standard solution gave a LOD relative
to the AZM peak, the LOD was 6.75 mg/ml. A ratio of 10 was
selected and successive dilutions of the reference standard
solution gave a LOQ relative to the AZM peak, the LOQ was
22.50 mg/ml, indicating that the HPLCeELSDmethod is precise
and sensitive for the quantitative evaluation of AZM.
3.4.5. Accuracy
The accuracy of the new method was evaluated by analyzing
the quality control of samples spiked with standard solutions
Table 4 e Results of repeatability test for AZM in
pharmaceutical raw materials and formulations by
HPLCeELSD.
AZM formulations Weighing
(mg)
Content
(%)
Mean
(%)
RSD
(%)
Raw materials 27.56 94.2 93.4 0.9
28.10 91.8
28.41 93.8
27.65 93.1
28.84 93.6
28.57 93.6
Capsules 35.30 97.8 99.7 1.4
35.56 100.0
35.01 98.0
35.52 101.1
35.73 100.8
35.36 100.4
Injections 32.68 99.0 99.4 0.9
33.17 98.3
33.11 98.7
32.98 100.3
33.06 99.7
33.25 100.6
Tablets 42.26 90.1 92.0 1.2
42.07 92.3
41.26 91.4
42.41 92.2
41.84 92.5
41.18 93.4
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tions versus nominal concentrations (namely, recovery ex-
periments). A recovery study was performed by analysis of
simulated formulations at three concentrations, namely 80%,
100% and 120% of the labeled amount of AZM raw materials
and formulations. The results of the recovery of the three
concentrations of simulated AZM raw materials and formu-
lations are summarized in Table 3. As it is clear from Table 3,
all the values of RSD for different formulations recovery test
were found to be within specified limits, showing that the
recovery of the method was satisfactory.
3.4.6. Stability
The stability of the reference and sample solutions was tested
by using the sameworking standard for 0, 1, 2, 4, 6 and 8 hwith
the same mobile phase. Between runs, solutions were stored
at room temperature. The areas of the five peaks were calcu-
lated with RSD, RSD values were better than 2.0%.
3.4.7. Repeatability
The method repeatability was determined using six de-
terminations at 100% of the test concentration (0.25 mg/ml),
the following results are shown in Table 4. RSD values are
given for each AZM. In every case, RSD valueswere better than
1.5% indicating the repeatability of the proposed method is
acceptable.
3.4.8. Durability
We determined the effect of different ratio of organic phase
and pH values of aqueous phase, of column temperature, and
of flow rate, using sample solution for the durability study.
The chromatographic conditions investigated are listed in
Table 5. It is apparent from this table that changing the col-
umn temperature had a noticeable effect on AZM chromato-
graphic peak shape and AZM content. While, changing the
flow rate had an obvious effect on the content of AZM but
almost no effect on AZM chromatographic peak shape.
Changing the ratio of organic phase and the pH of the aqueous
phase had no detectable effect on the chromatographic
system.Table 3 e Results of recovery test for AZM in
pharmaceutical raw materials and formulations by
HPLCeELSD.
AZM formulations Spiking
level (%)
Recovery
(%)
RSD
(%, n ¼ 9)
80 100.7
Raw materials 100 100.1 0.8
120 101.0
80 100.5
Capsules 100 100.8 0.7
120 100.7
80 99.9
Injections 100 100.5 0.8
120 99.4
80 101.2
Tablets 100 101.2 0.5
120 101.33.5. Application to analysis of pharmaceutical
formulations
The proposed HPLCeELSD method was applied for the
determination of AZM in commercial formulations by
assaying raw materials, capsules, injections and tablets. The
assay showed the AZM content of these products to be within
pharmacopeial limits. The results obtained with the pro-
posed method for the analysis of AZM were compared with
the experimental data investigated by those standard
methods (HPLCeUV [7] or microbiological method [8]). Table 6
shows the results of each method. According to the variance
ratio test (F-test and t-test), the calculated values of F and t
listed in Table 6 indicate that there is no significant differ-
ence between the HPLCeELSD method and HPLCeUV or
microbiological method.Table 5 e Values of variables used in the durability study.
Variable LV/As/
Content
CV/As/
Content
HV/As/
Content
Organic phase ratio 36/1.15/93.4 40/1.18/93.7 44/1.39/94.0
Aqueous phase pH 8.1/1.53/93.9 8.3/1.52/92.2 8.5/1.38/93.9
Column temperature
(C)
25/1.71/94.0 40/1.51/93.9 45/1.35/88.4
Flow rate (ml min1) 0.6/1.56/95.5 0.8/1.47/93.5 1.0/1.58/89.6
LV: low value of variable; CV: current value of variable; HV: high
value of variable; As: asymmetry of AZM peak.
Table 6 e Assay of AZM antibiotic in pharmaceutical raw materials and formulations with the ELSD and UV or
microbiological method (n[ 4).
Samples Batch
number
Claimed
(mg)
ELSD
method (%)
UV methoda (%) Microbiological
methodb (%)
F-testc t-testc
Raw materials 106110731 93.5 93.9 1.16 0.694
106110732 93.5 93.7 1.69 0.469
Capsules 1111181 100.4 99.4 1.82 0.943
1101022 250 101.6 100.2 1.60 2.054
1101044 104.4 105.0 1.64 0.661
Injections 100108-5 99.4 99.8 3.19 1.149
100108-6 250 99.3 99.7 2.17 2.026
100212-6 97.8 97.4 1.61 0.780
Tablets 1108407-1 92.4 91.7 3.06 1.153
1109458-1 250 91.6 92.1 2.27 1.525
1109458-2 91.2 90.8 1.10 1.063
a UV method refers to Chinese Pharmacopoeia vol. 2 (2010).
b Microbiological method refers to National Drug Standards of State Food and Drug Administration.
c Theoretical values of F and t at 95% confidence limit (n ¼ 4) are 9.28 and 2.447, respectively.
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As is shown by the method validation and method compari-
son, there was no significant difference between the
HPLCeELSD method and the standard methods (HPLCeUV or
microbiological method). Despites the logarithmic relation-
ship of ELSD signal to the analyte concentration, strong
detectability, precision, accuracy and repeatability were ob-
tained. Therefore, a simple high-performance liquid chro-
matography (HPLC) method coupled with an evaporative light
scattering detector (ELSD) appears to be efficient for the
qualification and quantification of AZM in raw materials and
pharmaceutical preparations (capsules, tablets and injections)
without any pretreatment or derivatization step.Acknowledgments
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